Virtu Financial LLC Biocept Inc Transaction History

Virtu Financial LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 15, 2023	BUY	$0.47 - $0.89 $10,810 - $20,470	23,001 New	23,001 $12,000
Q2 2022 Aug 09, 2022	BUY	$0.88 - $2.27 $24,816 - $64,016	28,201 New	28,201 $27,000
Q3 2021 Nov 12, 2021	SELL	$3.39 - $4.34 $64,423 - $82,477	-19,004 Closed	0 $0
Q2 2021 Sep 17, 2021	BUY	$4.03 - $5.07 $76,586 - $96,350	19,004 New	19,004 $80,000
Q1 2021 May 19, 2021	SELL	$4.74 - $7.94 $69,426 - $116,297	-14,647 Closed	0 $0
Q4 2020 Feb 24, 2021	BUY	$4.31 - $6.16 $63,128 - $90,225	14,647 New	14,647 $65,000

Ticker BIOC
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 16,922,900
Market Cap $1.18M
Description
Biocept, Inc., a molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating cell-free tumor DNA and RNA assays utilizing a standard blood sample. Its cancer assays provide information to healthcare providers to identify oncogenic alterations that qualify a subset of cancer patients for ...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.